J. Trédaniel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)

E. Quoix, B. Mennecier, G. R. Ferretti, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

A. Cazes, O. Molinier, J. Trédaniel, 2021, Cancers.

Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease.

C. Gisselbrecht, M. Boiron, J. Trédaniel, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.

N. Girard, E. Devin, J. Muir, 2022, The Lancet. Oncology.

Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe.

W. Ahrens, E. Riboli, H. Wichmann, 1998, Journal of the National Cancer Institute.

Peripheral T cell lymphoma following angioimmunoblastic lymphadenopathy.

C. Gisselbrecht, M. Boiron, G. Flandrin, 1987, Nouvelle revue francaise d'hematologie.

Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France

I. Durand-zaleski, J. Trédaniel, P. Piedbois, 2012, PharmacoEconomics.

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Nancy E. Marion, B. Delclaux, B. Asselain, 2022, The Lancet regional health. Europe.

Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

J. Trédaniel, G. Zalcman, A. Khalil, 2022, Cancers.

Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction.

J. Trédaniel, G. Zalcman, C. Hennequin, 1994, Chest.

Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study.

J. Trédaniel, G. Zalcman, D. Moro-Sibilot, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

B. Milleron, S. Laporte, J. Trédaniel, 2007, Revue des maladies respiratoires.

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

J. Trédaniel, M. Wislez, V. Gounant, 2022, Targeted Oncology.

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

J. Trédaniel, M. Rethoré, D. Satgé, 2013 .

Adenocarcinoma of the lung in Down syndrome: first clinical report.

J. Trédaniel, M. Rethoré, D. Satgé, 2013, Tumori.

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.

N. Girard, H. Blons, J. Trédaniel, 2019, Lung cancer.

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

B. Milleron, O. Molinier, S. Laporte, 2011, The Lancet.

Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice

J. Pignon, J. Soria, J. Trédaniel, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib

Takashi Takahashi, J. Trédaniel, P. Forgez, 2014, Oncotarget.

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

J. Trédaniel, P. Forgez, Jean Trédaniel, 2013, Front. Endocrin..

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.

L. Fournel, J. Trédaniel, E. Ségal-Bendirdjian, 2019, Cancer letters.

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

H. Blanché, J. Trédaniel, G. Zalcman, 2015, European Respiratory Journal.

[Targeted agents in the treatment of lung cancer].

J. Trédaniel, L. Staudacher, R. Cohen, 2012, Pathologie-biologie.

nine c cases a and r review o of t the l literature

C. Gisselbrecht, J. Trédaniel, P. Brice, 1994 .

Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.

P. Laurent-Puig, J. Peyrat, T. Soussi, 1993, Cancer research.

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

J. Trédaniel, M. Nishi, Jean Trédaniel, 2016, Lung cancer international.

The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.

C. Gisselbrecht, É. Lepage, J. Trédaniel, 1992, The European respiratory journal.

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

P. Validire, J. Trédaniel, P. Innominato, 2017, Oncotarget.

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002

N. Girard, T. Schuster, M. Olivier, 2014, Clinical Cancer Research.

[Intrabronchial curietherapy. Experiences at Hôpital Saint-Louis after the treatment of 149 patients].

D. Gossot, J. Trédaniel, G. Zalcman, 1997, Revue des maladies respiratoires.

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.

J. Blay, G. Ferretti, J. Mazières, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[Atmospheric air pollution and lung cancer: epidemiologic data].

D. Gossot, J. Trédaniel, C. Hennequin, 2009, Revue des maladies respiratoires.

[Smoking habits of French general practitioners. Results of a representative sample of 1,012 physicians].

J. Trédaniel, S. Karsenty, A. Hirsch, 1993, Revue des maladies respiratoires.

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

J. Trédaniel, L. Staudacher, C. Hennequin, 2010 .

Update : Vinorelbine in the Treatment of non-small-cell Lung cancer

J. Trédaniel, L. Staudacher, C. Hennequin, 2010 .

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

P. Guénel, P. Laurent-Puig, H. Blons, 2021, BMC Cancer.

Exposure tto eenvironmental ttobacco ssmoke and aadult nnon-neoplastic rrespiratory ddiseases

P. Boffetta, J. Trédaniel, R. Saracci, 1994 .

Environmental tobacco smoke and the risk of cancer in adults.

P. Boffetta, J. Trédaniel, R. Saracci, 1993, European journal of cancer.

Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study)

P. Guénel, P. Laurent-Puig, H. Blons, 2022, International journal of environmental research and public health.

Non-smoker lung cancer deaths attributable to exposure to spouse's environmental tobacco smoke.

P. Boffetta, J. Trédaniel, R. Saracci, 1997, International journal of epidemiology.

Exposure to environmental tobacco smoke and adult non-neoplastic respiratory diseases.

P. Boffetta, J. Trédaniel, R. Saracci, 1994, The European respiratory journal.

Exposure to environmental tobacco smoke and risk of lung cancer: the epidemiological evidence.

P. Boffetta, J. Trédaniel, R. Saracci, 1994, The European respiratory journal.

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

B. Milleron, J. Trédaniel, G. Zalcman, 2016, European journal of cancer.

Endobronchial presentation of Hodgkin's disease: a report of nine cases and review of the literature.

C. Gisselbrecht, J. Trédaniel, P. Brice, 1994, The European respiratory journal.

Tobacco smoking and gastric cancer: Review and meta‐analysis

Rodolfo Saracci, Paolo Boffetta, P. Boffetta, 1997, International journal of cancer.

Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence.

J. Little, P. Boffetta, J. Trédaniel, 1994, Paediatric and perinatal epidemiology.

Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE).

J. Blay, B. Asselain, S. Koscielny, 2007, Critical reviews in oncology/hematology.

Decision making process in oncology practice: is the information available and what should it consist of?

J. Blay, B. Asselain, S. Koscielny, 2005, Critical reviews in oncology/hematology.

Misclassification of smoking status among women in relation to exposure to environmental tobacco smoke.

E. Riboli, D. Trichopoulos, S. Preston‐Martin, 1995, The European respiratory journal.

Misclassification o of s smoking s status a among w women iin relation tto e exposure tto e environmental ttobacco s smoke

E. Riboli, D. Trichopoulos, S. Preston‐Martin, 1995 .

The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma.

D. Planchard, P. Validire, J. Soria, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.

S. Chevret, J. Trédaniel, C. Hennequin, 1998, International journal of radiation oncology, biology, physics.

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer

B. Milleron, O. Molinier, J. Trédaniel, 2013, European Respiratory Journal.

Do the nonsmoking daughters of smokers tend to marry smokers? Implications for epidemiological research on environmental tobacco smoke: the IARC collaborative study.

E. Riboli, H. Becher, E. Fontham, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Co-carcinogenic effects in rats of combined exposure to radon and ozone

J. Trédaniel, R. Maximilien, J. Morlier, 1996 .

[Tobacco use disorder].

J. Trédaniel, A. Hirsch, 1998, La Revue du praticien.

1273OResults of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

E. Devin, J. Lafitte, J. Trédaniel, 2017 .

Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment.

C. Gisselbrecht, M. Boiron, É. Lepage, 1990, Nouvelle revue francaise d'hematologie.

Dose repartition in alveoli, alveolar ducts, and bronchi of rats exposed to radon and its progeny, preliminary results

J. Trédaniel, P. Fritsch, J. Morlier, 1995 .

Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.

L. Fournel, P. Giraud, I. Cremer, 2020, European journal of cancer.

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.

L. Fournel, O. Melander, J. Trédaniel, 2019, Cancer letters.

An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

S. Culine, J. Trédaniel, J. Alexandre, 2009, Lung cancer.

[Why screen for lung cancer in patients with arterial disease?].

J. Trédaniel, P. Priollet, M. Lederlin, 2015, Journal des maladies vasculaires.

Thymic metastasis from lung carcinoma.

P. Demondion, D. Gossot, P. Validire, 2011, Interactive cardiovascular and thoracic surgery.

Long-term results of endobronchial brachytherapy: A curative treatment?

L. Quéro, J. Trédaniel, G. Zalcman, 2007, International journal of radiation oncology, biology, physics.

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

J. Trédaniel, M. Wislez, C. Chouaid, 2018, ERJ Open Research.

Fluoxetin-induced pulmonary granulomatosis.

M. Espié, J. Trédaniel, G. Zalcman, 1996, The European respiratory journal.

OA 16.03 Recurrences and 2nd Primary Cancers in the IFCT-0302 Trial Assessing a CT-Scan-Based Follow-Up after Lung Cancer Surgery

N. Girard, J. Lafitte, J. Muir, 2017 .

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study.

T. Payen, J. Trédaniel, L. Moreau, 2020, Respiratory medicine and research.

Eﬀicacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

J. Trédaniel, M. Wislez, E. Giroux-Leprieur, 2023 .

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302).

E. Devin, J. Lafitte, J. Trédaniel, 2012 .

Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank

J. Pastre, P. Laurent-Puig, M. Neri, 2017, BMC Public Health.

A Misleading Pulmonary Lesion in a Patient with Acute Monoblastic Leukemia

V. Meignin, T. Leblanc, J. Trédaniel, 2000, Leukemia & lymphoma.

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

T. Soussi, R. Lubin, J. Trédaniel, 1994, British Journal of Cancer.

Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer.

T. Soussi, R. Lubin, J. Trédaniel, 1994, Chest.

ILIAD: An Expert System for Diagnostic Assistance and Teaching: Implementation in France

Omar Bouhaddou, Éric Lepage, Homer R. Warner, 1991, MIE.

Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature.

G. Chatellier, M. Zins, J. Trédaniel, 2021, Journal de medecine vasculaire.

Diagnosis and standardized report for non-small cell lung cancer.

M. Revel, J. Trédaniel, M. Carette, 2014, Diagnostic and interventional imaging.

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study

G. Chatellier, E. Messas, M. Zins, 2019, BMC Cardiovascular Disorders.

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.

J. Trédaniel, F. Barlesi, M. Wislez, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.